New Nordic Healthbrands AB (publ) (STO:NNH)
Sweden · Delayed Price · Currency is SEK 14.55
-0.50 (-3.32%)
Nov 2, 2026, 4:42 PM CET
STO:NNH Ratios and Metrics
Market cap in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 90 | 144 | 93 | 103 | 180 | 548 | |
Market Cap Growth | -41.80% | 54.67% | -9.91% | -42.59% | -67.20% | 55.63% |
Enterprise Value | 121 | 171 | 128 | 125 | 218 | 548 |
Last Close Price | 15.05 | 22.83 | 14.76 | 16.38 | 28.54 | 84.08 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 19.89 | 17.54 | - | - | - | 25.71 |
PS Ratio | 0.16 | 0.25 | 0.17 | 0.19 | 0.37 | 1.06 |
PB Ratio | 0.86 | 1.39 | 0.92 | 0.97 | 1.60 | 4.55 |
P/TBV Ratio | 0.92 | 1.41 | 0.94 | 0.98 | 1.61 | 4.58 |
P/FCF Ratio | 1553.96 | 18.98 | - | 3.99 | - | - |
P/OCF Ratio | 1434.43 | 17.14 | - | 3.68 | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.21 | 0.30 | 0.23 | 0.24 | 0.45 | 1.07 |
EV/EBITDA Ratio | 9.11 | 10.14 | - | - | - | 18.69 |
EV/EBIT Ratio | 10.58 | 11.26 | - | - | - | 19.21 |
EV/FCF Ratio | 2068.13 | 22.52 | - | 4.85 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.35 | 0.35 | 0.39 | 0.27 | 0.44 | 0.20 |
Debt / EBITDA Ratio | 2.80 | 2.13 | - | - | - | 0.83 |
Debt / FCF Ratio | 635.75 | 4.73 | - | 1.11 | - | - |
Net Debt / Equity Ratio | 0.28 | 0.19 | 0.24 | 0.14 | 0.35 | 0.10 |
Net Debt / EBITDA Ratio | 2.27 | 1.15 | -8.52 | -7.72 | -10.68 | 0.43 |
Net Debt / FCF Ratio | 514.17 | 2.55 | -3.62 | 0.58 | -2.31 | -1.41 |
Asset Turnover | 2.21 | 2.33 | 2.21 | 2.13 | 1.99 | 2.40 |
Inventory Turnover | 1.90 | 1.95 | 1.85 | 1.73 | 1.49 | 1.67 |
Quick Ratio | 0.76 | 0.84 | 0.80 | 0.86 | 0.89 | 0.92 |
Current Ratio | 1.54 | 1.60 | 1.55 | 1.64 | 1.73 | 1.99 |
Return on Equity (ROE) | 4.29% | 8.02% | -7.44% | -5.67% | -2.42% | 18.93% |
Return on Assets (ROA) | 2.73% | 3.82% | -1.11% | -0.79% | -1.21% | 8.30% |
Return on Invested Capital (ROIC) | 3.85% | 8.01% | -3.62% | -2.32% | -3.34% | 19.01% |
Return on Capital Employed (ROCE) | 10.50% | 14.30% | -4.30% | -2.90% | -4.20% | 23.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 5.03% | 5.70% | -8.29% | -6.00% | -1.57% | 3.89% |
FCF Yield | 0.06% | 5.27% | -7.12% | 25.09% | -9.49% | -1.62% |
Dividend Yield | 1.72% | 1.08% | - | - | - | 1.41% |
Payout Ratio | 34.19% | - | - | - | - | 43.62% |
Total Shareholder Return | 1.72% | 1.08% | - | - | - | 1.41% |